| Identification | Back Directory | [Name]
butyl isobutyl phthalate | [CAS]
17851-53-5 | [Synonyms]
butyl isobutyl phthalate
n-Butyl iso-butyl phthalate
Phthalic acid 1-butyl 2-isobutyl ester
Phthalic acid 1-(2-methylpropyl)2-butyl ester
n-Butylisobutyl phthalate (n-Butyl-2-methylpropyl phthalate)
1,2-Benzenedicarboxylic acid, 1-butyl 2-(2-methylpropyl) ester | [EINECS(EC#)]
241-802-2 | [Molecular Formula]
C16H22O4 | [MDL Number]
MFCD11114531 | [MOL File]
17851-53-5.mol | [Molecular Weight]
278.34 |
| Chemical Properties | Back Directory | [Boiling point ]
315.7±10.0 °C(Predicted) | [density ]
1.051±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
Chloroform (Slightly), Ethyl Acetate (Slightly) | [form ]
Oil | [color ]
Colourless | [InChI]
InChI=1S/C16H22O4/c1-4-5-10-19-15(17)13-8-6-7-9-14(13)16(18)20-11-12(2)3/h6-9,12H,4-5,10-11H2,1-3H3 | [InChIKey]
UVIVWIFUPKGWGF-UHFFFAOYSA-N | [SMILES]
C1(C(OCCCC)=O)=CC=CC=C1C(OCC(C)C)=O |
| Hazard Information | Back Directory | [Uses]
Butyl Isobutyl Phthalate, is a volatile constituent of the ligarine extracts of twig, leaf and root of Clerodendrum inerme, having antioxidant properties. | [in vivo]
Butyl isobutyl phthalate (intragastric administration; 25, 50 or 100 mg/kg; 3 days) results in a more significant reduction in the blood glucose level, with the concentration of blood glucose being 11.50, 8.60 and 6.50 mM, respectively[1]. | Animal Model: | Streptozocin induced diabetic mice (Male Kunming mice)[1] | | Dosage: | 25, 50 or 100 mg/kg | | Administration: | Intragastric administration | | Result: | Had the observed antidiabetes activity in mice. |
|
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|